Advertisement

Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases

      Abstract

      Adults with congenital heart diseases may not be candidates for conventional therapies to control ventricular systolic dysfunction, including mechanical circulatory support, which moves potential heart-transplantation recipients to a listing status of higher priority. This results in longer waitlist times and greater mortality rates. Exception-status listing allows a pathway for this complex and anatomically heterogenous group of patients to be listed for heart transplantation at appropriately high listing status. Our study queried the United Network for Organ Sharing registry to evaluate trends in the use of exception-status listing among adults with congenital heart diseases awaiting heart transplantation. Uptrend in the use of exception-status listing precedes the new allocation system, but it has been greatest since changes were made in the allocation system. It continues to remain a vital pathway for adults with congenital heart disease (whose waitlist mortality rates are often not characterized adequately by using the waitlist-status criteria) timely access to heart transplantation.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Organ Procurement and Transplantation Network/United Network for Organ Sharing Thoracic Organ Transplantation Committee. Proposal to Modify the Adult Heart Allocation System. [accessed March 20, 2021]. Available from: https://optn.transplant.hrsa.gov/media/2006/thoracic_brief_201612.pdf.

      2. Electronic Code of Federal Regulations. Title 42: Public Health. Part 121: Organ Procurement and Transplantation Network. [accessed March 20, 2021]. Available from: http://www.ecfr.gov/cgi-bin/text-idx?SID=bb60e0a7222f4086a88c31211cac77d1&mc=true&node=pt42.1.121&rgn=div5#se42.1.121_18.

        • Colvin M
        • Smith JM
        • Hadley N
        • Skeans MA
        • Carrico R
        • Uccellini K
        • et al.
        OPTN/SRTR 2016 Annual Data Report: Heart.
        Am J Transplant. 2018;; 18: 291-362
      3. Organ Procurememt and Transplantation Network. Modify Adult Heart Allocation 2016 2nd Round. [accessed March 20, 2021]. Available from: https://optn.transplant.hrsa.gov/governance/public-comment/modify-adult-heart-allocation-2016-2nd-round/.

        • Goldberg SW
        • Fisher SA
        • Wehman B
        • Mehra MR
        • et al.
        Adults with congenital heart disease and heart transplantation: optimizing outcomes.
        J Heart Lung Transplant. 2014; 33: 873-877
        • Alshawabkeh LI
        • Hu N
        • Carter KD
        • Opotowsky AR
        • Light-McGroary K
        • Cavanaugh JE
        • et al.
        Wait-list outcomes for adults with congenital heart disease listed for heart transplantation in the U.S.
        J Am Coll Cardiol. 2016; 68: 908-917
        • Karamlou T
        • Hirsch J
        • Welke K
        • Ohye RG
        • Bove EL
        • Devaney EJ
        • et al.
        A united network for organ sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation.
        J Thorac Cardiovasc Surg. 2010; 140: 161-168
        • Davies RR
        • Russo MJ
        • Yang J
        • Quaegebeur JM
        • Mosca RS
        • Chen JM
        • et al.
        Listing and transplanting adults with congenital heart disease.
        Circulation. 2011; 123: 759-767
        • Chouairi F
        • Mullan CW
        • Sen S
        • Mori M
        • Fuery M
        • Elder RW
        • et al.
        Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies.
        PLoS One. 2021; 16e0247789
        • Menachem JN
        • Schlendorf KH
        • Mazurek JA
        • Bichell DP
        • Brinkley DM
        • Frischhertz BP
        • et al.
        Advanced heart failure in adults with congenital heart disease.
        JACC Heart Fail. 2020; 8: 87-99
      4. Review board (RB) guidance for adult congenital heart disease (chd) exception requests. [accessed March 20, 2021]. Available from: https://optn.transplant.hrsa.gov/media/2349/thoracic_guidance_201712.pdf.

        • Kovach JR
        • Naftel DC
        • Pearce FB
        • Tresler MA
        • Edens RE
        • Shuhaiber JH
        • et al.
        Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the Pediatric Heart Transplant Study.
        J Heart Lung Transplant. 2012; 31: 133-139
        • John AS
        • Johnson JA
        • Khan M
        • Driscoll DJ
        • Warnes CA
        • Cetta F
        • et al.
        Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation.
        J Am Coll Cardiol. 2014; 64: 54-62
        • Griffiths ER
        • Kaza AK
        • Wyler von Ballmoos MC
        • Loyola H
        • Valente AM
        • Blume ED
        • et al.
        Evaluating failing Fontans for heart transplantation: predictors of death.
        Ann Thorac Surg. 2009; 88 (discussion 563–4): 558-563
        • Gewillig M
        • Brown SC
        The Fontan circulation after 45 years: update in physiology.
        Heart. 2016;; 102: 1081-1086